Extracellular vesicles: A promising therapy against SARS-CoV-2 infection.

Authors :: Leyfman Y
Gohring G
Joshi M
Menon GP
Van de Kieft A
Rivero TD
Bellio MA
Mitrani MI
Source :: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2023 May 03; Vol. 31 (5), pp. 1196-1200.
Publication Year :: 2023
Abstract: Competing Interests: Declaration of interests G.G., M.I.M., T.d.R., and M.A.B. are employees of Organicell Regenerative Medicine. M.I.M. is the Chief Science Officer, serves on the Organicell Regenerative Medicine Board of Directors, and holds equity in the company.

Language :: English
ISSN :: 1525-0024
Volume :: 31
Issue :: 5
Database :: MEDLINE
Journal :: Molecular therapy : the journal of the American Society of Gene Therapy
Publication Type :: Academic Journal
Accession number :: 37141856
Full Text :: https://doi.org/10.1016/j.ymthe.2023.03.033